Wells Fargo
KMTS

Wells Fargo’s Kestra Medical Technologies KMTS Stock Holding History

Wells Fargo’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
25,445
+14,850
+140% +$311K ﹤0.01% 4429
2026
Q1 		$211K Sell
10,595
-11,753
-53% -$277K ﹤0.01% 4677
2025
Q4 		$593K Buy
22,348
+13,325
+148% +$343K ﹤0.01% 4363
2025
Q3 		$214K Buy
9,023
+1,326
+17% +$23.7K ﹤0.01% 4899
2025
Q2 		$128K Buy
7,697
+6,997
+1,000% +$153K ﹤0.01% 5056
2025
Q1 		$17.4K Buy
+700
New +$16.1K ﹤0.01% 5750

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wells Fargo's KMTS Position: Q2 2026 in Review

Wells Fargo increased its Kestra Medical Technologies (KMTS) stake by 140% in Q2 2026, buying an estimated $311K and bringing the position to 25,445 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #4429.

Wells Fargo first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Wells Fargo held 25,445 shares of Kestra Medical Technologies worth $647K as of Q2 2026.
  • Wells Fargo bought 14,850 Kestra Medical Technologies shares in Q2 2026, an estimated $311K.
  • Kestra Medical Technologies made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4429 holding.
  • Wells Fargo first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.